mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.33 |
5e-20 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.31 |
2e-18 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.33 |
8e-18 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.31 |
2e-16 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
7e-16 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-12 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-09 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-09 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
5e-09 |
mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
5e-09 |